SC

Siddharth Chhaganbhai Gajera

Active Director Director DIN 11693011
DIN 11693011 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Siddharth Chhaganbhai Gajera

Data last updated:

Siddharth Chhaganbhai Gajera is a Director at Chon Pharma Chem Private Limited (since 2026).

DIN 11693011
Primary Designation Director
First Appointment 29 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chon Pharma Chem Private Limited U20119GJ2026PTC177264
Director29 Apr 20262026Active

Board colleagues of Siddharth Chhaganbhai Gajera

Directorship timeline

Open interactive timeline →
Chon Pharma Chem Private Limited
Premium access

Shareholding and investment profile for Siddharth Chhaganbhai Gajera

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Siddharth Chhaganbhai Gajera

Siddharth Chhaganbhai Gajera currently holds 1 directorship: Chon Pharma Chem Private Limited (Director, since 29 Apr 2026).

Siddharth Chhaganbhai Gajera was first appointed on 29 Apr 2026 as Director at Chon Pharma Chem Private Limited.

The current boards of Siddharth Chhaganbhai Gajera's companies include Chintan Natvarlal Moradiya (Chon Pharma Chem Private Limited), Jagdishkumar Nanjibhai Godhasra (Chon Pharma Chem Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available